Trial Details
COMPLETEDBasic Information
| Clinical ID | c3127 |
|---|---|
| Identifier | NCT02495623 |
| Trial Title | A Study of the Effect of SYN-010 on Subjects With IBS-C |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Irritable Bowel Syndrome With Constipation (IBS-C) |
| Interventions | DRUG: SYN-010 21 mg|DRUG: SYN-010 42 mg|DRUG: Placebo |
Participant Information
| Sponsor | Theriva Biologics, Inc. |
|---|---|
| City | Miami |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2015-06 |
|---|---|
| Primary Completion Date | 2015-10 |
| Completion Date | 2015-11 |